This invention provides fully human monoclonal antibodies that recognize IL- 17F and/or the heterodimeric IL-17A/IL-17F complex, but do not recognize IL- 17A. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.